Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 216-913-4 | CAS number: 1696-20-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2011-07-20 to 2012-06-20
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant study according to guideline.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- (July 22, 2010)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Version / remarks:
- (2003)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 4-acetylmorpholine
- EC Number:
- 216-913-4
- EC Name:
- 4-acetylmorpholine
- Cas Number:
- 1696-20-4
- Molecular formula:
- C6H11NO2
- IUPAC Name:
- 1-(morpholin-4-yl)ethan-1-one
- Details on test material:
- - Name of test material: Acetylmorpholin
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: Pre-test: CBA/CaOlaHsd; main study: CBA/CaCrl
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories B.V., Horst, The Netherlands
- Age at study initiation: 8 - 9 (pre-test and main study)
- Weight at study initiation: 16.8 g to 20.1 g
- Housing: grouped in Makrolon Type II / III, with wire mesh top
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: At least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature: 22 + 2°C
- Humidity: 45-66%
- Photoperiod: 12h light / 12h darkness; 6.00 a.m. - 6.00 p.m.
IN-LIFE DATES: not specified
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Remarks:
- 25% (w/v)
- Concentration:
- 0, 25, 50 and 100%
- No. of animals per dose:
- five females
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: good solubility in acetone/olive oil; as a liquid, it is also applicable undiluted (100%).
- Irritation: From day 3 to day 6, both animals treated with either 75 or 100% of the test item showed an erythema of the ear skin (75% test item concentration: Score 1 on day 3 to 6; 100% test item concentration: Score 2 on day 3 and Score 1 from day 4 to 6). However, the thresholsd value for the ear weight or ear thickness values of 25% for excessive local skin irritation mentioned in OECD guideline 429 was not exceeded at any concentration.
- Lymph node proliferation response: not determined.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Local Lymph Node Assay (LLNA) in Mice
- Criteria used to consider a positive response: First, that exposure to at least one concentration of the test item resulted in an incorporation of 3HTdR at least 3-fold or greater than that recorded in control mice, as indicated by the Stimulation Index. Second, that the data are compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression.
TREATMENT PREPARATION AND ADMINISTRATION:
Each test group of mice was treated by topical (epidermal) application to the dorsal surface of each ear with test item concentrations of 25 and 50% (w/v) in acetone:olive oil (4+1 v/v), and 100% (undiluted test item). The application volume, 25 µL/ear/day, was spread over the entire dorsal surface (appr. 8 mm on average) of each ear once daily for three consecutive days. Two further groups of mice (a vehicle control group and a positive control group) were treated with an equivalent volume of the vehicle alone or with the positive control item at 25% (w/v).
Five days after the first topical application (day 6) 250 µL of phosphate-buffered saline (PBS) containing 19.9 µCi of 3HTdR (equivalent to 79.6 µCi/mL 3HTdR) were injected into each test and control mouse via the tail vein. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- One-Way-Analysis-of-Variance (SigmaStat for Windows, Version 2.0): DPM values, ear weights, lymph node weights and lymph node cell count. If significant: Dunnett test.
Outliers: Dean-Dixon-Test and Grubb’s test (performed using Microsoft Excel 2003).
Results and discussion
- Positive control results:
- When compared to the vehicle control group, the positive control (HCA) resulted in a stimulation index (SI) of 7.97, providing evidence for the validity of the assay.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: SI Test Group / Treatment / Stimulation Index (mean) 1 / 0% / 1.00 2 / 25% / 2.91 3 / 50% / 2.30 4 / 100% / 4.01 5 / pos. contr. / 7.97 EC3 value of 70.5% (w/v) (based on 50 % and 100%)
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Test Group / Treatment / [DPM/Lymph Node Pair (mean)] 1 / 0% / 369.3 2 / 25% / 1074.1 3 / 50% / 847.7 4 / 100% / 1479.7 5 / pos.contr. / 2942.1 Calculation: test group x / test group 1 (vehicle control)
Any other information on results incl. tables
A statistically significant (p<0.05) and biologically relevant increase in the DPM value and lymph node weight was observed at the highest dose group in comparison to the vehicle control group; referring to the lymph node weight, this was also the case for the low dose group. A statistically significant increase in lymph node cell count was not observed in any treated group in comparison to the vehicle control group. For BALB/c mice, a cut off-value for the lymph node cell count index of 1.55 was reported for a positive response. The indices determined for the lymph node cell count did not exceed this threshold. Still, based on the Stimulation Index obtained for the high dose group, which exceeded the threshold value of 3 for a positive response, the test item has to be regarded as a skin sensitizer. Based on the S.I.s obtained with 50% and 100% test item concentration, an EC3 value of 70.5% (w/v) was calculated.
An outlier was identified in the high dose group (DPM value determined for animal number 17). However, as the corresponding lymph node weight value confirmed the result of the DPM value and as exclusion of the outlier did not change the overall test result, the value in question was not excluded from calculation.
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.